Clinitech Laboratory (BOM:544220) ROCE % : 8.62% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Clinitech Laboratory ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Clinitech Laboratory's annualized ROCE % for the quarter that ended in Sep. 2024 was 8.62%.

Clinitech Laboratory ROCE % Historical Data

The historical data trend for Clinitech Laboratory's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinitech Laboratory ROCE % Chart

Clinitech Laboratory Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

ROCE %

31.58

34.66

27.93

14.02

Clinitech Laboratory Semi-Annual Data
	Mar21	Mar22	Mar23	Sep23	Mar24	Sep24
ROCE %	Get a 7-Day Free Trial			-	-	5.92	27.58	8.62

Clinitech Laboratory ROCE % Calculation

Clinitech Laboratory's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	5.786	/	( ( (60.333 - 17.57)	+	(56.079 - 16.317) )	/ 2 )
	=	5.786	/	( (42.763	+	39.762)	/ 2 )
	=	5.786	/	41.2625
	=	14.02 %

Clinitech Laboratory's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Mar. 2024 )		(Q: Sep. 2024 )
	=	5.936	/	( ( (56.079 - 16.317)	+	(110.364 - 12.456) )	/ 2 )
	=	5.936	/	( ( 39.762	+	97.908 )	/ 2 )
	=	5.936	/	68.835
	=	8.62 %

(1) Note: The EBIT data used here is two times the semi-annual (Sep. 2024) EBIT data.

Clinitech Laboratory (BOM:544220) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Clinitech Laboratory ROCE % Related Terms

Thank you for viewing the detailed overview of Clinitech Laboratory's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clinitech Laboratory Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clinitech Laboratory Ltd (BOM:544220) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

AL-1/545 and 546, Sector 16, Opposite Radhikabai Meghe Vidyalaya, Airoli, Navi Mumbai, MH, IND, 400708

Website

https://www.ctllab.in

Clinitech Laboratory Ltd is e a provider of diagnostic and healthcare tests and services through chain of 8 diagnostic centers in and around Thane and Navi Mumbai. It conduct more than 150 tests such as Biochemistry tests, Immunology tests, Hematology tests, Molecular Biology tests, Serology tests, Microbiology tests, etc.

Clinitech Laboratory Headlines

No Headlines